News
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2021.* Novocure is a global oncology company
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate
Puma Biotechnology Releases Updated Corporate Presentation
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, provided an update to the corporate presentation that its Chief Executive Officer and President, Alan H. Auerbach, presented at
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Pfizer Inc. (NYSE: PFE) and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, today announced they
Investor and Analyst Event: Exelon Details Strategy for Nation’s Largest Fully Regulated Utility Company
Exelon Corp. (Nasdaq: EXC) will host an investor and analyst event today, January 10, beginning at 12:00 p.m. Central Time, 1:00 p.m. Eastern Time. Exelon management will outline how the company is
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.
Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI) and Apria, Inc. (“Apria”) (Nasdaq: APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases
Pfizer Inc. (NYSE: PFE) and Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced an exclusive four-year
DGAP-News: H&R GmbH & Co. KGaA: Joint Venture P2X Europe and Nordic Electrofuel cooperate on PtL products
NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
DGAP-News: INDUS Holding AG: INDUS places second ESG-linked promissory note loan
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the closing of its previously announced acquisition of Ivantis®, developer of the
EQS-News: Nordea Bank Abp: Transaction in Own Shares
DGAP-News: MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
DGAP-News: Successful year-end sprint 2021 - total transaction volume of DIC up to c. EUR 1.9 billion
NanoString Announces Commercial Leadership Transition
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a commercial leadership transition. Chad Brown, who
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for
DGAP-News: Steinhoff International Holdings N.V. : Mattress Firm Group Inc. Files Registration Statement on Form S-1 for Proposed Initial Public Offering
Lomiko Announces Private Placement
Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the “TSX”) for a non-brokered
Semtech Supports Development of LoRa®-enabled Applications for Social and Environmental Use Cases
Semtech Corporation (Nasdaq: SMTC), a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, has entered into a consulting arrangement with
Essex Announces Release and Conference Call Dates for Its Fourth Quarter 2021 Earnings
Essex Property Trust, Inc. (NYSE:ESS) announced today that it plans to release its fourth quarter 2021 earnings after the market closes on Wednesday, February 2, 2022. A conference call with senior
Cushman & Wakefield Expands Appraisal Platform in North Carolina through Asset Acquisition
Cushman & Wakefield (NYSE: CWK) announced the firm has acquired substantially all of the assets of North by Northwest Consulting (NxNW), a valuation services firm led by Anthony Alderman and based
UBS Declares Coupon Payments on 12 ETRACS Exchange Traded Notes
UBS Investment Bank today announced coupon payments for 12 ETRACS Exchange Traded Notes (the “ETNs”), all traded on the NYSE Arca.
NYSE Ticker
ETN Name and Prospectus
Supplement*